title: Modification of autolysis by synthetic peptides derived from the presumptive binding domain of Staphylococcus aureus autolysin.
abstract: The autolytic cell wall hydrolase of Staphylococcus aureus, Atl, contains three highly cationic repeats in the central region of the amino acid sequence, and the repeats are presumed to have the role of binding the enzyme to some components on the cell surface. To explain the possible function of the repeats, we synthesized a number of 10- to 30-mer oligopeptides based on the Atl amino acid sequence (Thr432-Lys610) containing repeat 1, and examined their effects on the autolysis of S. aureus cells. When the peptides were added to a cell suspension of S. aureus under low ionic strength conditions, five peptides, A10, A11, A14, A16 and B9, showed immediate increases in optical density (OD) of the cell suspension accompanied by decreases in viable cell counts. After the immediate increases, the ODs for A10 and A14 changed little in the first 2 hr. In contrast, the ODs for A11 and A16 decreased rapidly. When peptide A10 was added to suspensions of heat-killed whole cells, crude cell walls and a crude peptidoglycan preparation, their ODs were increased approximately 2-fold. In contrast, the OD was not increased when the peptide was added to a suspension of pure peptidoglycan from which anionic polymers had been removed. Light microscopic and transmission electron microscopic study showed that A10 and A14 inhibited autolysis and that A11 and A16 induced autolysis earlier than the control. These results suggest strongly that the peptides adsorb to and precipitate on the anionic cell surface polymers such as teichoic acid and lipoteichoic acid via ionic interaction. The effects of peptides on the autolysis may be the results of the modification of S. aureus autolysin activities. These peptides, especially the 10-mer peptide B9 (PGTKLYTVPW) that represents the C-terminal half of A10 and N-terminal half of A11, may be important segments for Atl to bind to the cell surface.
authors.affiliation: Pharmaceutical Development Research Laboratory, Tanabe Seiyaku Co., Ltd., Saitama, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Takano
authors.forename: T
authors.initials: T
authors.lastname: Oshida
authors.forename: A
authors.initials: A
authors.lastname: Yasojima
authors.forename: M
authors.initials: M
authors.lastname: Yamada
authors.forename: C
authors.initials: C
authors.lastname: Okagaki
authors.forename: M
authors.initials: M
authors.lastname: Sugai
authors.forename: H
authors.initials: H
authors.lastname: Suginaka
authors.forename: T
authors.initials: T
authors.lastname: Matsushita
mesh_terms: D000595:Amino Acid Sequence; D001433:Bacteriolysis; D001665:Binding Sites; D002473:Cell Wall; D008969:Molecular Sequence Data; D009238:N-Acetylmuramoyl-L-alanine Amidase / Q000138:chemical synthesis / Q000378:metabolism*; D009842:Oligopeptides / Q000138:chemical synthesis / Q000378:metabolism*; D009994:Osmolar Concentration; D013211:Staphylococcus aureus / Q000378:metabolism*
chemical_list: D009842:Oligopeptides; D009238:N-Acetylmuramoyl-L-alanine Amidase